Niagen Bioscience, Inc. (NAGE) stock
NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3015% below fair value
$1.94−0.10 (-4.90%)
Close on Nov 18, 2026Market cap $153.50MP/E 16.2Yield –
Niagen Bioscience operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Niagen Bioscience's operating cash flow for the twelve months ending Sep 30, 2026 was $4.88M, down 77.2% year over year. For fiscal 2025 it was $13.50M, up 11.5% from the year before. The highest annual figure on record is $13.50M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.50M | +11.5% |
| FY2024 | Dec 31, 2024 | $12.11M | +70.1% |
| FY2023 | Dec 31, 2023 | $7.12M | – |
| FY2022 | Dec 31, 2022 | -$15.10M | – |
| FY2021 | Dec 31, 2021 | -$24.16M | – |
| FY2020 | Dec 31, 2020 | -$10.60M | – |
| FY2019 | Dec 31, 2019 | -$20.44M | – |
| FY2018 | Dec 31, 2018 | -$20.91M | – |
| FY2017 | Dec 30, 2017 | -$9.80M | – |
| FY2016 | Dec 31, 2016 | -$2.94M | – |
| FY2015 | Jan 2, 2016 | -$2.11M | – |
| FY2014 | Jan 3, 2015 | -$2.58M | – |
| FY2013 | Dec 28, 2013 | -$3.91M | – |
| FY2012 | Dec 29, 2012 | -$10.12M | – |
| FY2011 | Dec 31, 2011 | -$4.10M | – |
| FY2010 | Jan 1, 2011 | -$2.66M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.63M | -28.9% |
| Q2 FY2026 | Jun 30, 2026 | $2.77M | +121.8% |
| Q1 FY2026 | Mar 31, 2026 | -$1.19M | -115.1% |
| Q4 FY2025 | Dec 31, 2025 | $679.00K | -92.1% |
| Q3 FY2025 | Sep 30, 2025 | $3.69M | +5.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.25M | – |
| Q1 FY2025 | Mar 31, 2025 | $7.88M | +2572.2% |
| Q4 FY2024 | Dec 31, 2024 | $8.58M | +1222.5% |
| Q3 FY2024 | Sep 30, 2024 | $3.50M | +782.6% |
| Q2 FY2024 | Jun 30, 2024 | -$264.00K | -108.0% |
| Q1 FY2024 | Mar 31, 2024 | $295.00K | -89.4% |
| Q4 FY2023 | Dec 31, 2023 | $649.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $396.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $3.28M | – |
| Q1 FY2023 | Mar 31, 2023 | $2.79M | – |
| Q4 FY2022 | Dec 31, 2022 | -$328.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.74M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.83M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.20M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.94M | -22572.7% |
| Q3 FY2021 | Sep 30, 2021 | -$5.92M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.90M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.41M | – |
| Q4 FY2020 | Dec 31, 2020 | $22.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.85M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.56M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.22M | – |
| Q4 FY2019 | Dec 31, 2019 | -$610.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.76M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.05M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.14M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.24M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.55M | -3524.9% |
| Q1 FY2018 | Mar 31, 2018 | -$3.99M | – |
| Q4 FY2017 | Dec 30, 2017 | -$3.77M | – |
| Q3 FY2017 | Sep 30, 2017 | -$475.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $191.19K | – |
| Q3 FY2016 | Oct 1, 2016 | -$140.40K | – |
See a number that looks wrong?